Table 1 Cross-section analysis of the response to treatment between week 24 and 156 and also 218 to 256 (25 visits) for all 38 completers included in this study
Never n (%)>0 and⩽25%of all visits n (%)>25 and⩽50%of all visits n (%)>50 and⩽75%of all visits n (%)>75 and<100%of all visits n (%)100%of all visits n (%)
ASAS 20%1 (2.6)02 (5.3)3 (7.9)10 (26.3)22 (57.9)
ASAS 40%3 (7.9)5 (13.2)1 (2.6)4 (10.5)10 (26.3)15 (39.5)
Partial remission 22 (57.9)2 (5.3)04 (10.5)6 (15.8)4 (10.5)
“ASAS 5 out of 6”*3 (7.9)3 (7.9)3 (7.9)5 (13.2)5 (13.2)19 (50.0)
  • Numbers are n of patients, numbers in brackets are % of patients.